Phase 3 STAMPEDE trial data demonstrates Decipher Prostate test can predict docetaxel treatment benefit, potentially helping patients avoid unnecessary toxicity.
This marks the first time a US Food and Drug Adminstration-authorized self-collection device is available for at-home cervical cancer screening in the US.
A new survey reveals declining cancer screening rates among U.S. adults, but shows strong interest in innovative screening methods.
Vibrant Wellness has enhanced its Gut Zoomer microbiome panel with expanded microbial and metabolite testing.
Read More
A new prospective study in BMC Cancer shows that the blood-based multi-omics test SeekInClarity accurately predicts treatment outcomes.
Read More
Lunit has partnered with Microsoft to co-develop scalable, AI-powered healthcare solutions that enhance cancer detection.
Read More
AMP has published consensus best practice recommendations to standardize HRD testing in clinical laboratories.
Read More
Researchers have developed genomic biomarkers to predict cancer patients’ resistance to chemotherapy, enabling more personalized treatment.
Read More
Lucid Diagnostics and Hoag have launched a comprehensive esophageal precancer screening program using the non-endoscopic EsoGuard DNA test.
Read More
CAP has updated 23 cancer protocols to align with the latest standards from AJCC and WHO, enhancing diagnostic precision and patient care.
Read More
Researchers have developed an AI blood test called Fragle to accurately and affordably track cancer treatment response and detect relapse.
Read More
ClearNote Health and University Hospital Southampton have launched the SAFE-D study to evaluate the Avantect Pancreatic Cancer Test.
Read More
Emerging liquid biopsy techniques enable sensitive, routine monitoring of ESR1 mutations in metastatic HR+ breast cancer.
Read More
Quest Diagnostics is partnering with MD Anderson Cancer Center to develop a lab-based blood test for cancer that uses protein biomarkers.
Read More
Echosens and Boehringer Ingelheim have expanded their partnership to improve early detection, diagnosis, and care access for MASH.
Read More
Florida Cancer Specialists & Research Institute now offers liquid biopsy, a minimally invasive blood test that enhances cancer diagnosis.
Read More
It can take over a decade for unnecessary cancer screenings to significantly decline after updated guidelines advise against them.
Read More
A study found that colorectal cancer screening could be boosted by using a rapid, accurate app-read smartphone FIT.
Read More